AI TEAMMATES FOR CLINICAL RESEARCH
LIVE

Serial Number

99254794

Owner

Tilda Research Inc.

Attorney

Michael Markos

First Use Date

Oct 27, 2019

Filing Date

Jun 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

AI TEAMMATES FOR CLINICAL RESEARCH Trademark

Serial Number: 99254794

AI TEAMMATES FOR CLINICAL RESEARCH is a trademark filed by Tilda Research Inc. on June 26, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Tilda Research Inc.

14642 Newport Ave Ste 350
Tustin, CA 92780

Entity Type: 03

Trademark Details

Filing Date

June 26, 2025

Registration Date

Not Registered

First Use Anywhere

October 27, 2019

First Use in Commerce

October 27, 2019

Goods & Services

Platform as a service (PAAS) featuring computer software platforms for managing and automating clinical trial operations and clinical research study administration, namely, software platforms for automated study management; study setup and maintenance, real-time centralized monitoring of clinical trial data for trial oversight and decision making, regulatory compliance management and inspection readiness; clinical site selection and activation, real-time visibility into patient enrollment, identifying subjects and recruiting faster, simplifying screening and scheduling, minimizing clinical trial data entry; automating live document updates, and automated payment tracking and follow-up for clinical trial site payments; Scientific research in the nature of conducting clinical trials for others

Business management and consultation in the field of clinical trial operations and clinical research study management for sponsors, contract research organizations (CROs), and clinical research sites, namely, business consultation regarding planning, coordinating, and managing clinical trial study setup and maintenance, clinical site selection and activation, trial monitoring and quality oversight, protocol compliance, patient enrollment visibility, subject identification and recruitment, and clinical trial site financial performance and payment tracking

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 15, 2026 RCSC
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 15, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2026 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 14, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 14, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jan 14, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 14, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 26, 2025 MAFR
NEW APPLICATION ENTERED
Jun 26, 2025 NWAP